Figure 1From: The current status of targeting BAFF/BLyS for autoimmune diseasesInteractions of BAFF and its homologs with the three BAFF receptors. Sites of action of potential blockers are described in Table 1. APRIL, a proliferation-inducing ligand; BAFF-R, BAFF receptor; BCMA, B cell maturation antigen; ΔBAFF, alternatively spliced form of BAFF that does not bind to BAFF receptors; TACI, transmembrane activator and calcium modulator ligand interactor; TWE-PRIL, a fusion protein of TWEAK (TNFSF12) and APRIL.Back to article page